Evidence map›Paper›PMID 40942944›Full record

ArticleSensors (Basel, Switzerland)2025

Machine Learning-Based Alexithymia Assessment Using Resting-State Default Mode Network Functional Connectivity.

Kei Suzuki, Midori Sugaya

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kei SuzukiFunctional Control Systems, Graduate School of Engineering and Science, TOYOSU Campus, Shibaura Institute of Technology, Research Building #14A32, 3-7-5 Toyosu, Koto-ku, Tokyo 135-8548, Japan.
Midori SugayaFunctional Control Systems, Graduate School of Engineering and Science, TOYOSU Campus, Shibaura Institute of Technology, Research Building #14A32, 3-7-5 Toyosu, Koto-ku, Tokyo 135-8548, Japan.ORCID 0000-0003-3297-5913

Funding

Japan Society for the Promotion of Science JP23KJ1924
6 · The paper itself

Abstract

Alexithymia is regarded as one of the risk factors for several prevalent mental disorders, and there is a growing need for convenient and objective methods to assess alexithymia. Therefore, this study proposes a method for constructing models to assess alexithymia using machine learning and electroencephalogram (EEG) signals. The explanatory variables for the models were functional connectivity calculated from resting-state EEG data, reflecting the default mode network (DMN). The functional connectivity was computed for each frequency band in brain regions estimated by source localization. The objective variable was defined as either low or high alexithymia severity. Explainable artificial intelligence (XAI) was used to analyze which features the models relied on for their assessments. The results indicated that the classification model suggested effective assessment depending on the threshold used to define low and high alexithymia. The maximum receiver operating characteristic area under the curve (ROC-AUC) score was 0.70. Furthermore, analysis of the classification model indicated that functional connectivity in the theta and gamma frequency bands, and specifically in the Left Hippocampus, was effective for alexithymia assessment. This study demonstrates the potential applicability of EEG signals and machine learning in alexithymia assessment.

Indexed as

Affective SymptomsDefault Mode NetworkMachine LearningAdultBrainElectroencephalographyFemaleHumansMaleROC CurveYoung Adultalexithymiadefault mode networkelectroencephalogrammachine learningsource localization

Identifiers

PMID40942944
PMCPMC12431339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.